Coronavirus: Vaccination

(asked on 6th June 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will expand the spring covid-19 booster vaccine rollout to include people with motor neurone disease who are clinically extremely vulnerable.


Answered by
Maggie Throup Portrait
Maggie Throup
This question was answered on 9th June 2022

During the spring booster vaccination programme, an additional dose is being offered to residents in care homes for older adults, individuals aged 12 years old and over who are immunosuppressed and adults aged 75 years old and over. The Joint Committee on Vaccination and Immunisation (JCVI) do not currently recommend a further dose for those with motor neurone disease, unless the existing criteria applies.

The JCVI continues to consider the latest available data, particularly in relation to the timing and value of any further doses. On 19 May 2022, the JCVI published interim advice on an autumn COVID-19 booster programme. The JCVI advises that a booster dose should be offered to residents in care homes for older adults and staff; frontline health and social care workers; all those aged 65 years old and over; and adults aged 16 to 64 years old who are in a clinical risk group, such as motor neurone disease.

The JCVI will continue to review the vaccination programme, the definitions of clinical risk groups and the epidemiological situation to inform its final advice. The Government will consider the JCVI's final advice before determining which groups should be included in the autumn COVID-19 booster programme.

Reticulating Splines